WIRE — Pune (Maharashtra) [India], July 16 (ANI): The Gates Medical Research Institute (Gates MRI) on Thursday signed an agreement with the Serum Institute of India Private Limited (SII) to manufacture a novel tuberculosis (TB) vaccine candidate M72/AS01E. Currently in a Phase 3 clinical trial, M72/AS01E has the potential to be the first new TB vaccine to be introduced in more than a century - a potential breakthrough
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.